Fingerprint
Dive into the research topics of 'Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer
Philip A. Philip, Michelle R. Mahoney, Cristine Allmer, James Thomas, Henry C. Pitot, George Kim, Ross C. Donehower, Tom Fitch, Joel Picus, Charles Erlichman
Research output: Contribution to journal › Article › peer-review
421
Scopus
citations